Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Journal of Medical Council of Islamic Republic of Iran. 2012; 30 (1): 36-41
in Persian | IMEMR | ID: emr-160982

ABSTRACT

Obstructive sleep disorders and their effects on dental and maxillofacial growth has long been debated. Adenotonsillar hypertrophy as the most common cause of Obstructive sleep disorders with its consequent impact on dental growth has recently gained greater attention and its treatment may help prevent or reverse these effects. In this corss-sectional study 120 children were enrolled. 60 patients assigned to undergo adenotonsillectomy for obstructive sleep disorders were compared with 60 children without obstructive sleep disorders. Both groups were matched in terms of gender and age. Dental casts and measurements with caliper were used. Crowding of upper and lower teeth, anterior open bite, posterior cross bite, overjet, class II malocclusion, width of upper and lower dental arches were documented and compared. Differences were found in crowding of upper and lower teeth, anterior open bite, posterior cross bite, overjet, class II malocclusion and width of upper and lower dental arches. This study suggests the effects of obstructive sleep disorders on dental growth, probably due to the long term impact of the position of the head, mandible and tongue to keep the airway open in oral breathing

2.
Journal of Research in Medical Sciences. 2010; 34 (2): 92-97
in Persian | IMEMR | ID: emr-108504

ABSTRACT

Corticosteroids are used for the management of allergic rhinitis. We compared the efficacy of systemic and local corticosteroid in symptom relief and serum IgE levels in patients with perennial allergic rhinitis. A randomized experimental study design, [clinical trial] was used. 86 patients with a history of perennial allergic rhinitis were selected and randomly divided in two groups. For the first group systemic corticosteroids were given in the form of prednisolone tablet 5mg twice daily, [10mg/day], tapered every 3 days. For the second group, Beclomethasone nasal spray 50 micro g/puff was administered twice daily as two puffs in each nostril for three weeks. Rhinorrhea, nose and eye itching, sneezing, nasal obstruction and serum IgE before and after treatment, [3weeks] were evaluated and compared. We found a significant decrease in serum IgE in both groups but the decrease was more marked with systemic corticosteroids [P<0.05]. After therapy the percentage of sneezing and eye itching decreased significantly in the systemic corticosteroid group and percentage of rhinorrhea decreased significantly in the local corticosteroid group. Pre and post intervention evaluations showed improvement in all symptoms in systemic corticosteroid group and all symptoms except eye itching in local corticosteroid group. The result of this comparative study showed that systemic corticosteroids are more efficient in improvement of sneezing and eye itching but local corticosteroids may have a better efficacy in the improvement of nasal obstruction


Subject(s)
Humans , Prednisolone , Prednisolone/administration & dosage , Beclomethasone , Immunoglobulin E/blood , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL